Methoxyflurane

甲氧氟烷

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameMethoxyflurane
Drug Alias Name二氟二氯乙基甲醚methoxyfluranummetoxiflurano甲氧基氟氯乙烷Penthrox +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAcute PainPainST Elevation Myocardial Infarction +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[9] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaDiscontinued
Originator CompaniesMedical Developments International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of ManitobaMedical Developments International Ltd
Inactive CompaniesAbbott LaboratoriesUniversity of SydneyMundipharma Pharmaceuticals Sl +[4] 
Active IndicationsAcute PainST Elevation Myocardial InfarctionTesticular Hydrocele +[7] 
Inactive IndicationsPainNeoplasms

Other Information

ATC CodeN02BG09
Related LinksWikipediaDrugBankKEGG